))
282: Lilly’s obesity drug, the power of radiation, & a biotech implosion
Manage episode 382979112 series 2986293
Kandungan disediakan oleh STAT. Semua kandungan podcast termasuk episod, grafik dan perihalan podcast dimuat naik dan disediakan terus oleh STAT atau rakan kongsi platform podcast mereka. Jika anda percaya seseorang menggunakan karya berhak cipta anda tanpa kebenaran anda, anda boleh mengikuti proses yang digariskan di sini https://ms.player.fm/legal.
As so-called radiopharmaceuticals make headlines in oncology, we explore their fascinating scientific backstory and the biotech gold rush to make them. We also discuss the approval of Eli Lilly’s curiously named treatment for obesity, the latest implosion for a promising biotech company, and some news in the world of shareholder activism.
To keep up between podcast episodes, here’s where you can subscribe to our biotech newsletter, The Readout.
308 episod
Kongsi
